AllDocs -> cancers

When cells in the liver become abnormal, grow out of control and form a cancerous tumor, the disease is called primary liver cancer , also known as malignant hepatoma or hepatocellular carcinoma. (“Hepato” means “ liver .”) Primary liver cancer is not the same disease as cancer that spreads (metastasizes) to the liver from another part of the body (secondary liver cancer ). The liver is often the site of secondary tumors that result from the spread of cancer from another organ, such as the colon or breast. The cancer cells in the secondary tumor are like those of the original cancer , the primary cancer , which is named for the part of the body in which it began. Thus, cancer that begins in the colon or breast and spreads to the liver is called metastatic colon cancer or metastatic breast cancer . What are ...

Deleted in Liver Cancer (DLC) 2 Encodes a RhoGAP Protein with Growth Suppressor Function and Is Underexpressed in Hepatocellular Carcinoma* Received for publication, August 14, 2002, and in revised form, January 12, 2003 Published, JBC Papers in Press, January 16, 2003, DOI 10.1074/jbc.M208310200 Yick-Pang Ching‡§, Chun-Ming Wong§ ¶ , Shing-Fai Chan , Thomas Ho-Yin Leung ¶ , David Chi-Heng Ng , Dong-Yan Jin‡ **‡‡, and Irene Oi-lin Ng ¶ ‡‡ From the ‡ Institute of Molecular Biology, the ¶ Department of Pathology, and the Department of Biochemistry, University of Hong Kong, Hong Kong, China Hepatocellular carcinoma (HCC) is a major malig- nancy in many parts of the world, especially in Asia and Africa. Loss of heterozygosity (LOH) on the long arm of chromosome 13 has been reported in HCC. In ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com * Findings were statistically significant (strong evidence) + Evidence of a dose-response relationship (strongest evidence) Page 57 Liver Cancer and (including intra-hepatic bile duct) Exposure to Ionizing Radiation Summary: Moderately strong evidence has been recorded of a possible connection between liver cancer deaths and exposure to ionizing radiation. This evidence is based upon studies conducted at Los Alamos National Laboratory, studies of nuclear workers at other sites, and others exposed to ionizing radiation. These findings are consistent with the National Research Council’s determination that the liver is sensitive to ionizing radiation. Liver cancer is designated as ...

Fox Chase Cancer Center 2002 Scientific Report Clearance of Infected Hepatocytes During the Resolution of a Transient Hepadnavirus Infection. Mason, Aldrich, Saputelli, Zhu, a in collaboration with Litwin, § Jilbert, b Summers c Hepadnavirus infections in adults normally clear after a few months. Prior to clearance, every hepatocyte may be infected. Infection of every hepatocyte may also characterize chronic infections but, in this case, the immune response allows a persistent disease without clearing the virus. A goal of our research is therefore to characterize how virus is elimi- nated during resolution of transient infections and, in the long term, whether this same pro- cess can be induced, to cure chronic infections. To study the fate of infected hepatocytes during a transient infection, we infected ...

J. RADIAT. RES., 42, 117–130 (2001) *Corresponding author: Phone: 81– 822– 61–1937, Fax: 81– 822– 62– 9768, Email: sharp@rerf.or.jp Abbreviations: CC, cholangiocarcinoma; CI, confidence interval; HbsAg, hepatitis-B surface antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; LET, linear-energy transfer; LSS, Life Span Study; OR, odds ratio; RBE, relative biologic effectiveness; RERF, Radiation Effects Research Foundation; Sv, Sievert Liver Cancer in Atomic-bomb Survivors: Histological Characteristics and Relationships to Radiation and Hepatitis B and C Viruses TOSHIYUKI FUKUHARA 1 , GERALD B. SHARP 2,3 *, TERUMI MIZUNO 4 , HIDEYO ITAKURA 5 , MASAMI YAMAMOTO 6 , MASAYOSHI TOKUNAGA 7 , SHOJI TOKUOKA 2 , JOHN B. COLOGNE 8 ...

INTERNATIONAL TRENDS AND PATTERNS OF PRIMARY LIVER CANCER Katherine A. M C G LYNN *, Lilian T SAO , Ann W. H SING , Susan S. D EVESA and Joseph F. F RAUMENI J R . Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA Primary liver cancer (PLC) is common in many areas of the developing world, but uncommon in most of the devel- oped world. Some evidence suggests, however, that the global pattern of PLC may be changing. To clarify this issue, we examined incidence rates for PLC over the 15-year time period, 1978 –92, in selected cancer registries around the world. With some exceptions, developed countries have ex- perienced PLC increases in incidence whereas developing countries have experienced declines. Although ...

Overview Numerous surgical advances and the involvement of surgeons early in the evalua- tion of liver lesions have resulted in the ability to resect more liver malignancies with lower rates of operative mortality. At California Pacific, a medical-surgical team including an oncologist, hepatologist, radiologist and surgeon work together on all hepatocellular carcinoma (HCC) cases, evaluating patients’ ability to tolerate a liver resection or other treatment regimens. Because time is critical after the diagnosis of HCC, patients who are not candidates for resection should be referred immediately for possible ablative therapy, chemotherapy and/or liver transplantation if indicated. Tumor Detection Initially, liver cancer is hard to detect. Patients typically don’t feel any differently as most tumors are asymptomatic. For this reason, ...

On January 7, 2003, Dr. Joseph Buell (Division of Transplantation) led a team of surgeons performing a new procedure for patients with metastatic unresectable cancers of the liver . Team members includ- ed Dr. Steve Libutti from the NIH and UC surgeons Dr. Steve Rudich (Director of Liver Transplantation) and Drs. Syed Ahmad and Jeffrey Sussman (Division of Surgical Oncology). The procedure, Isolated Hepatic Perfusion (IHP) with Melphalan, has been under clinical evalua- tion for almost 40 years. The Department of Surgery at University Hospital is the first to offer this therapy outside of the NIH and a group in Amsterdam. IHP represents the ultimate refinement in regional treatment strategies in that the hepatic circulation can be completely isolated from the systemic circulation and perfused using an extra-corporeal bypass system with high-dose chemotherapy ...

Maxim Pharmaceuticals is a global biopharmaceutical company with a diverse pipeline of drug candidates for life - threatening cancers, hepatitis C and other chronic liver diseases. • Late-stage with four Phase 3 clinical trials • Pipeline targeting multi-billion dollar markets • Program in hepatitis C, a $2 billion market expected to grow to $7 billion by 2011 • Lead drug candidate Ceplene™ efficacy & safety demonstrated in 17 clinical trials in 20 countries • Seasoned, experienced pharmaceutical management • Leading clinical investigators and scientific advisors Ceplene therapy for melanoma represents Maxim’s most advanced program with seven clinical trials in more than 1,000 patients completed or underway. Ceplene clinical data and research has been presented at more than 80 major scientific and clinical ...

12 Apr 2003 No. 407 HIGHLIGHTS THIS WEEK Screening for liver cancer worth it in cirrhosis 7 The UK’s new layer of prescribers brings new opportunities 3 Atorvastatin cost saving in hypercholesterolaemia 5 Also available in a choice of flexible electronic delivery options – see back cover for details FULL CONTENTS ‘Activa’ therapy: coverage for US Medicare beneficiaries 11 Allergic rhinitis pharmacy management guideline released 4 Antibacterials overprescribed to paediatrics in Germany 7 Asthma: improved therapy compliance, higher costs 9 Atorvastatin cost saving in hypercholesterolaemia 5 ß-Blockers in clinical practice for heart failure in Italy 7 Breast cancer : QOL effect with care processes 10 Cancer : Wales takes the lead in UK care 2 Cardiovascular ...

Last revised: 4/10/03 UM Cancer Center Patient Education Document #0032 Apr03 Ed. Online version: http://www. cancer .med.umich.edu/learn/percpathways.htm University of Michigan Comprehensive Cancer Center Patient Education Resource Center (PERC) INFORMATION GUIDE Liver Cancer The purpose of this information guide is to help patients newly diagnosed with Liver Cancer and their families to find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center at the University of Michigan Comprehensive Cancer Center in room B1-361. Brochure Available free at the Patient Education Resource Center on Level B-1 National Cancer Institute. What You Need To Know About: ...

l del file contenuto in http://www.hkbu.edu.hk/~10scprhk/Org-abstract/O-82.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:hMduNbAM8sUJ:www.hkbu.edu.hk/~10scprhk/Org-abstract/O-82.doc+allintitle:+liver+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle liver cancer Title: To elucidate the role of DLC2 in the development of hepatocellular carcinoma. Authors: Andy KL Fung1, Hongzhe Sun1, DY Jin2, Stephen SM Chung3 and Ben CB Ko1 From the 1Open Laboratory of Chemical Biology of the ...

l del file contenuto in http://net3.hkbu.edu.hk/~chemd1/Org-abstract/O-82.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:4-3rVeJrGfUJ:net3.hkbu.edu.hk/~chemd1/Org-abstract/O-82.doc+allintitle:+liver+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle liver cancer Title: To elucidate the role of DLC2 in the development of hepatocellular carcinoma. Authors: Andy KL Fung1, Hongzhe Sun1, DY Jin2, Stephen SM Chung3 and Ben CB Ko1 From the 1Open Laboratory of Chemical Biology of the ...

Last Revised: 3/3/2003 UM Comprehensive Cancer Center Patient Education Document # 0015 Mar03 Ed. Online version: http://www. cancer .med.umich.edu/learn/percpathways.htm University of Michigan Comprehensive Cancer Center Patient Education Resource Center (PERC) INFORMATION GUIDE Childhood Cancer : Liver Cancers The purpose of this information guide is to help parents of children newly diagnosed with liver tumors find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center at the University of Michigan Comprehensive Cancer Center in room B1-361. Book Chapters Available for loan in the Patient Education Resource Center on level B1 room 361 Janes-Hodder, ...

N ORTHERN C ALIFORNIA C ANCER C ENTER , Cancer Incidence and Mortality in the Greater San Francisco Bay Area 111 Liver Cancer • Between 1988 and 2000, there was an overall slight increase in liver cancer incidence rates among all racial/ethnic groups except Asians/Pacific Islanders (Table 1). • Asians/Pacific Islanders had the highest incidence rate of liver cancer , nearly twice that of blacks and Hispanics and 4-times that of whites during the period 1996-2000 (Table 1). • Liver cancer rates were 3-times higher in males than in females (Table 1). • Liver cancer rates increased steadily with age, peaking in persons aged 75-79 (Table 2). • The incidence rate of liver cancer was higher in males of all racial/ethnic ...

258 N ORTHERN C ALIFORNIA C ANCER C ENTER , Cancer Incidence and Mortality in the Greater San Francisco Bay Area Liver Cancer TABLE 1. Liver Cancer . Annual Death Counts, Age-Adjusted Mortality Rates per 100,000 Population, a and 95% Confidence Intervals (CI), by Sex and Race/Ethnicity, 1988-2000, Greater San Francisco Bay Area b TOTAL MALES FEMALES Year Count Rate 95% CI Count Rate 95% CI Count Rate 95% CI ALL RACES 1988-1993 c 1,175 3.9 3.7-4.1 805 6.1 5.6-6.5 370 2.2 1.9-2.4 1994 237 4.4 3.8-5.0 177 7.5 6.4-8.8 60 2.0 1.5-2.6 1995 226 4.1 ...

NYS NYC 05 Staten Isl 04 Queens 03 Brooklyn 02 Bronx 01 Manhattan 62 Yates * 61 Wyoming * 60 Westchester 59 Wayne * 58 Washington * 57 Warren * 56 Ulster 55 Tompkins * 54 Tioga * 53 Sullivan * 52 Suffolk 51 Steuben * 50 Seneca * 49 Schuyler * 48 Schoharie * 47 Schenectady * 46 Saratoga * 45 St Lawrence * 44 Rockland 43 Rensselaer * 42 Putnam * 41 Otsego * 40 Oswego * 39 Orleans * 38 Orange * 37 Ontario * 36 Onondaga 35 Oneida * 34 Niagara 33 Nassau 32 Montgomery * 31 Monroe 30 Madison * 29 Livingston * 28 Lewis * 27 Jefferson * 26 Herkimer * 25 Hamilton * 24 Greene * 23 Genesee * 22 Fulton * 21 Franklin * 20 Essex * 19 Erie 18 Dutchess * 17 Delaware * 16 Cortland * 15 Columbia * 14 Clinton * 13 ...

NYS NYC 05 Staten Isl 04 Queens 03 Brooklyn 02 Bronx 01 Manhattan 62 Yates * 61 Wyoming * 60 Westchester 59 Wayne * 58 Washington * 57 Warren * 56 Ulster 55 Tompkins * 54 Tioga * 53 Sullivan * 52 Suffolk 51 Steuben * 50 Seneca * 49 Schuyler * 48 Schoharie * 47 Schenectady * 46 Saratoga 45 St Lawrence 44 Rockland 43 Rensselaer 42 Putnam * 41 Otsego * 40 Oswego * 39 Orleans * 38 Orange 37 Ontario * 36 Onondaga 35 Oneida 34 Niagara 33 Nassau 32 Montgomery * 31 Monroe 30 Madison * 29 Livingston * 28 Lewis * 27 Jefferson * 26 Herkimer * 25 Hamilton * 24 Greene * 23 Genesee * 22 Fulton * 21 Franklin * 20 Essex * 19 Erie 18 Dutchess 17 Delaware * 16 Cortland * 15 Columbia * 14 Clinton * 13 Chenango * ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:qQ-rMhzx1-gJ:www.stonybrookhospital.com/Cancerregistry/TU2C036.pdf allintitle: liver cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Liver Cancer What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells often travel to other parts of the body where they begin to grow and replace normal tissue. This process, called metastasis, occurs as the cancer cells get into the bloodstream or lymph vessels of our ...

A BASIC INFORMATION DESCRIPTION Uncontrolled growth of malignant cells in the liver . Liver cancer may be primarily resulting from abnormal liver or bile-duct cells, or it may result from spread of cancer from another site (metastases). The most com- mon sources are cancers of the rectum, colon, lung, breast, pancreas, esophagus or skin (malignant melanoma). Liver cancer can affect all ages, but is most common in men over 60. FREQUENT SIGNS AND SYMPTOMS • Loss of appetite and weight loss. • Tender mass in the right upper abdomen. • Pain in the upper abdomen. • Low fever, usually less than 101° F (38.3° C). • Yellow eyes and skin (sometimes). • Swollen abdomen from fluid retention (sometimes). • Lethargy. CAUSES Unknown. It occurs most often in population groups with a high incidence of viral hepatitis and other chronic liver ...

liver cancer Chemotherapy for colorectel liver metastasis and pancreatic cancer . Dr. Warwick Dobson Hepatopancreatobiliary Unit Alfred Hospital Liver Metastasis from Colorectal Cancer (LMCRC) Background 35% risk of developing CRC before age 74. Liver metastasis present in 40-60% of cases ~40% die with metastatic disease limited to liver Unresectable liver mets with chemotherapy alone; mean survival around 12-18 months LMCRC Treatment Surgery metastatic resection is the only treatment offering a cure only 10-15% of liver mets considered resectable resection mortality 2-5% five year survival post-resection ~ 25-45% recurrence post-resection 65-80% 5-fluorouracil Antimetabolite, inhibits DNA synthesis Toxicity stomatitis, ...

CA 125 and Liver Disease Mayo Clin Proc, June 2002, Vol 77 538 Mayo Clin Proc . 2002;77:538-541 538 © 2002 Mayo Foundation for Medical Education and Research Original Article Cancer Antigen 125 in Patients With Chronic Liver Disease H ARSHAD D EVARBHAVI , MD; D OROTHY K AESE , RN; A MY W. W ILLIAMS , MD; J ORGE R AKELA , MD; G EORGE G. K LEE , MD, P H D; AND P ATRICK S. K AMATH , MD From the Division of Gastroenterology and Hepatology and Internal Medicine (H.D., D.K., P.S.K.), Division of Nephrology and Internal Medicine (A.W.W.), and Department of Laboratory Medicine ...

Liver and Intra-Hepatic Bile Duct Cancer 54 CANCER INCIDENCE AND MORTALITY IN NEW MEXICO, 1970-1996 Major Epidemiologic Features Cancer of the liver and intra-hepatic bile duct is very common in parts of Asia and Africa but relatively rare in the U.S., accounting for about 1% of all annual cases. The disease is frequently lethal and mortality statistics generally approximate those for incidence. Moreover, because cancers from other sites of the body often spread to the liver , liver cancer mortality rates can be higher than corresponding incidence rates due to the inclusion of these secondary, or metastatic, liver cancers into the mortality statistics. The two most common forms of primary liver cancer , hepatocellular carcinoma and cholangiocarcinoma, arise from the liver cells and the bile ducts, respectively. Incidence and mortality rates in the U.S. were stable from ...

Any State 30 Year Fixed Rate Boston.com home News wires Northeast Nation Washington World Sports Business Technology Education Health Regional news All Northeast Massachusetts New Hampshire Rhode Island Maine Vermont Connecticut New York [ Send this story to a friend | Easy-print version ] Stanford Researcher Identifies Genes Pointing to Liver Cancer ; Advocates Screening for Asian Populations By Ascribe, 6/4/2002 14:37 STANFORD, Calif., June 4 (AScribe Newswire) -- Cancerous liver cells rely on a different set of genes than normal liver cells in order to function. Now researchers at Stanford University Medical Center have identified genes needed by cancerous liver cells ...